This site is intended for healthcare professionals only
LoginRegister
Nurse on night duty allegedly raped by doctor at Moradabad Hospital, 3 arrestedNurse on night duty allegedly raped by doctor at Moradabad Hospital, 3 arrested
CCTV Cameras, Control Room, Security Guards: Health Ministry Issues measures for Central Hospitals, AIIMS, INIs to Ensure Safety of Doctors, Health WorkersCCTV Cameras, Control Room, Security Guards: Health Ministry Issues measures for Central Hospitals,...
Will hurt my daughter if I accept money as compensation, says father of deceased doctor at RG Kar Medical CollegeWill hurt my daughter if I accept money as compensation, says father of deceased doctor at RG Kar...
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsStrides Pharma Science arm gets USFDA EIR for Alathur facility
Father of Murdered Doctor Calls Out Cover-Up, Demands CBI InvestigationKolkata doctor death case: CBI again inspects RG Kar Medical College Hospital
CENTAC Releases Seat Matrix, candidates List for Round 2 NEET MDS 2024 Counselling, DetailsCENTAC Releases Seat Matrix, candidates' List for Round 2 NEET MDS 2024 Counselling, Details
NMC Plans to Introduce Centralised Software System for MBBS AdmissionsNMC notifies on implementation of Nasha Mukt Bharat Abhiyan In All Medical Colleges
MCC Releases eligible NRI candidates List for NEET UG Round 1 Counselling 2024MCC Releases eligible NRI candidates List for NEET UG Round 1 Counselling 2024
MBBS, BDS Admissions 2024 In Haryana: Here is the complete Fee StructureMBBS, BDS Admissions 2024 In Haryana: Here is the complete Fee Structure
Pfizer Awards Rs 60 Lakh Each to 14 Healthtech Startups Under INDovation 2025Submit diagnosis criteria for lower respiratory infection and earlier study data: CDSCO Panel Tells...
DMER Haryana releases Tentative Schedule for Round 1 NEET Counselling for MBBS, BDS Admissions 2024, detailsDMER Haryana releases Tentative Schedule for Round 1 NEET Counselling for MBBS, BDS Admissions 2024,...
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaCDSCO Panel Approves AstraZeneca's protocol amendment proposal for COPD drug Tozorakimab
X